Physician gender is associated with the quality of type 2 diabetes care by Berthold, H. K., Gouni‐Berthold, I., Bestehorn, K. P., Böhm, M., Krone, W.

Get full text

Primary disorders of lipid metabolism: their place in current dyslipidemia guidelines and treatment innovations by Klose, G, Gouni-Berthold, I, März, W

Get full text

Vitamin D supplementation of 4000 IU daily and cardiac function in patients with advanced heart failure: The EVITA trial by Zittermann, A., Ernst, J.B., Prokop, S., Fuchs, U., Gruszka, A., Dreier, J., Kuhn, J., Knabbe, C., Berthold, H.K., Gouni-Berthold, I., Pilz, S., Gummert, J.F., Paluszkiewicz, L.

Get full text

Atherosclerotic disease location and disparities in the control and treatment of cardiovascular risk factors in patients with Type 2 diabetes by Berthold, H. K., Bestehorn, K. P., Krone, W., Gouni-Berthold, I.

Get full text

Vitamin D supplementation and bone turnover in advanced heart failure: the EVITA trial by Zittermann, A., Ernst, J. B., Prokop, S., Fuchs, U., Dreier, J., Kuhn, J., Berthold, H. K., Pilz, S., Gouni-Berthold, I., Gummert, J. F.

Get full text

Efficacy and Tolerability of Evolocumab vs Ezetimibe in Patients With Muscle-Related Statin Intolerance: The GAUSS-3 Randomized Clinical Trial by Nissen, Steven E, Stroes, Erik, Dent-Acosta, Ricardo E, Rosenson, Robert S, Lehman, Sam J, Sattar, Naveed, Preiss, David, Bruckert, Eric, Ceška, Richard, Lepor, Norman, Ballantyne, Christie M, Gouni-Berthold, Ioanna, Elliott, Mary, Brennan, Danielle M, Wasserman, Scott M, Somaratne, Ransi, Scott, Rob, Stein, Evan A

Get full text

Randomized supplementation of 4000 IU vitamin D3 daily vs placebo on the prevalence of anemia in advanced heart failure: the EVITA trial by Ernst, J. B, Prokop, S, Fuchs, U, Dreier, J, Kuhn, J, Knabbe, C, Berthold, H. K, Pilz, S, Gouni-Berthold, I, Gummert, J. F, Börgermann, J, Zittermann, A

Get full text

PCSK9 inhibition with evolocumab (AMG 145) in heterozygous familial hypercholesterolaemia (RUTHERFORD-2): a randomised, double-blind, placebo-controlled trial by Raal, Frederick J, Prof, Stein, Evan A, Prof, Dufour, Robert, MD, Turner, Traci, MD, Civeira, Fernando, MD, Burgess, Lesley, Prof, Langslet, Gisle, MD, Scott, Russell, Prof, Olsson, Anders G, Prof, Sullivan, David, MD, Hovingh, G Kees, MD, Cariou, Bertrand, MD, Gouni-Berthold, Ioanna, MD, Somaratne, Ransi, MD, Bridges, Ian, MSc, Scott, Rob, MD, Wasserman, Scott M, MD, Gaudet, Daniel, Prof

Get full text

Association of the promoter polymorphism −232C/G of the phosphoenolpyruvate carboxykinase gene (PCK1) with Type 2 diabetes mellitus by Gouni-Berthold, I., Giannakidou, E., Faust, M., Berthold, H. K., Krone, W.

Get full text

Randomized supplementation of 4000 IU vitamin D 3 daily vs placebo on the prevalence of anemia in advanced heart failure: the EVITA trial by Ernst, J B, Prokop, S, Fuchs, U, Dreier, J, Kuhn, J, Knabbe, C, Berthold, H K, Pilz, S, Gouni-Berthold, I, Gummert, J F, Börgermann, J, Zittermann, A

Get full text

Cognitive function in a randomized trial of evolocumab by Giugliano, Robert P, Mach, François, Zavitz, Kenton, Kurtz, Christopher, Im, Kyungah, Kanevsky, Estella, Schneider, Jingjing, Wang, Huei, Keech, Anthony, Pedersen, Terje Rolf, Sabatine, Marc S, Sever, Peter S, Robinson, Jennifer G, Honarpour, Narimon, Wasserman, Scott M, Ott, Brian R

Request full text

EU-Wide Cross-Sectional Observational Study of Lipid-Modifying Therapy Use in Secondary and Primary Care: the DA VINCI study by Ray, Kausik K, Molemans, Bart, Schoonen, W Marieke, Giovas, Periklis, Bray, Sarah, Kiru, Gaia, Murphy, Jennifer, Banach, Maciej, De Servi, Stefano, Gaita, Dan, Gouni-Berthold, Ioanna, Hovingh, G Kees, Jozwiak, Jacek J, Jukema, J Wouter, Kiss, Robert Gabor, Kownator, Serge, Iversen, Helle K, Maher, Vincent, Masana, Luis, Parkhomenko, Alexander, Peeters, André, Clifford, Piers, Raslova, Katarina, Siostrzonek, Peter, Romeo, Stefano, Tousoulis, Dimitrios, Vlachopoulos, Charalambos, Vrablik, Michal, Catapano, Alberico L, Poulter, Neil R

Get full text

Prevalence of LPA single nucleotide polymorphisms and isoforms in patients enrolled in a phase 2 IONIS-APO(a)Rx clinical trial by Stroes, E.S, van der Valk, F.M, Gaudet, D, Gouni-Berthold, I, Riksen, N.P, Steinhagen-Thiessen, E, Isermann, B, Nordestgaard, B, Viney, N.J, Marcovina, S, Hughes, S.G, Tami, J, Xia, S, Witztum, J.L, Tsimikas, S

Get full text

The effect of CCR2 inhibitor CCX140-B on residual albuminuria in patients with type 2 diabetes and nephropathy: a randomised trial by de Zeeuw, Dick, Prof, Bekker, Pirow, MBChB, Henkel, Elena, MD, Hasslacher, Christopher, MD, Gouni-Berthold, Ioanna, MD, Mehling, Heidrun, MD, Potarca, Antonia, MSc, Tesar, Vladimir, Prof, Heerspink, Hiddo J Lambers, PharmD, Schall, Thomas J, PhD

Get full text

Nutraceutical approaches to non-alcoholic fatty liver disease (NAFLD): A position paper from the International Lipid Expert Panel (ILEP) by Rizzo, Manfredi, Colletti, Alessandro, Penson, Peter E., Katsiki, Niki, Mikhailidis, Dimitri P., Toth, Peter P., Gouni-Berthold, Ioanna, Mancini, John, Marais, David, Moriarty, Patrick, Ruscica, Massimiliano, Sahebkar, Amirhossein, Vinereanu, Dragos, Cicero, Arrigo Francesco Giuseppe, Banach, Maciej, Acosta, Julio, Al-Khnifsawi, Mutaz, Alnouri, Fahad, Amar, Fahma, Atanasov, Atanas G., Bajraktari, Gani, Banach, Maciej, Gouni-Berthold, Ioanna, Bhaskar, Sonu, Bielecka-Dąbrowa, Agata, Bjelakovic, Bojko, Bruckert, Eric, Bytyçi, Ibadete, Cafferata, Alberto, Ceska, Richard, Cicero, Arrigo F.G., Chlebus, Krzysztof, Collet, Xavier, Daccord, Magdalena, Descamps, Olivier, Djuric, Dragan, Durst, Ronen, Ezhov, Marat V., Fras, Zlatko, Gaita, Dan, Gouni-Berthold, Ioanna, Hernandez, Adrian V., Jones, Steven R., Jozwiak, Jacek, Kakauridze, Nona, Kallel, Amani, Katsiki, Niki, Khera, Amit, Kostner, Karam, Kubilius, Raimondas, Latkovskis, Gustavs, John Mancini, G.B., David Marais, A., Martin, Seth S., Martinez, Julio Acosta, Mazidi, Mohsen, Mikhailidis, Dimitri P., Mirrakhimov, Erkin, Miserez, Andre R., Mitchenko, Olena, Mitkovskaya, Natalya P., Moriarty, Patrick M., Mohammad Nabavi, Seyed, Nair, Devaki, Panagiotakos, Demosthenes B., Paragh, György, Pella, Daniel, Penson, Peter E., Petrulioniene, Zaneta, Pirro, Matteo, Postadzhiyan, Arman, Puri, Raman, Reda, Ashraf, Reiner, Željko, Radenkovic, Dina, Rakowski, Michał, Riadh, Jemaa, Richter, Dimitri, Rizzo, Manfredi, Ruscica, Massimiliano, Sahebkar, Amirhossein, Serban, Maria-Corina, Shehab, Abdullah M.A, Shek, Aleksandr B., Sirtori, Cesare R., Stefanutti, Claudia, Tomasik, Tomasz, Toth, Peter P., Viigimaa, Margus, Valdivielso, Pedro, Vinereanu, Dragos, Vohnout, Branislav, von Haehling, Stephan, Vrablik, Michal, Wong, Nathan D., Yeh, Hung-I, Zhisheng, Jiang, Zirlik, Andreas

Get full text

whey fermentation product malleable protein matrix decreases triglyceride concentrations in subjects with hypercholesterolemia: A randomized placebo-controlled trial by Berthold, H.K, Schulte, D.M, Lapointe, J.F, Lemieux, P, Krone, W, Gouni-Berthold, I

Get full text

Resistin gene 3′‐untranslated region +62G→A polymorphism is associated with hypertension but not diabetes mellitus type 2 in a German population by GOUNI‐BERTHOLD, I., GIANNAKIDOU, E., FAUST, M., KRATZSCH, J., BERTHOLD, H. K., KRONE, W.

Get full text

Identification and diagnosis of patients with familial chylomicronaemia syndrome (FCS): Expert panel recommendations and proposal of an “FCS score” by Moulin, Philippe, Dufour, Robert, Averna, Maurizio, Arca, Marcello, Cefalù, Angelo B., Noto, Davide, D'Erasmo, Laura, Di Costanzo, Alessia, Marçais, Christophe, Alvarez-Sala Walther, Luis Antonio, Banach, Maciej, Borén, Jan, Cramb, Robert, Gouni-Berthold, Ioanna, Hughes, Elizabeth, Johnson, Colin, Pintó, Xavier, Reiner, Željko, van Lennep, Jeanine Roeters, Soran, Handrean, Stefanutti, Claudia, Stroes, Erik, Bruckert, Eric

Get full text

Lipoprotein metabolism in patients with anorexia nervosa: a case–control study investigating the mechanisms leading to hypercholesterolaemia by Weinbrenner, T., Züger, M., Jacoby, G. E., Herpertz, S., Liedtke, R., Sudhop, T., Gouni-Berthold, I., Axelson, M., Berthold, H. K.

Get full text

Comparison of a new long-acting testosterone undecanoate formulation vs testosterone enanthate for intramuscular androgen therapy in male hypogonadism by Minnemann, T., Schubert, M., Freude, S., Hübler, D., Gouni-Berthold, I., Schumann, C., Christoph, A., Oettel, M., Ernst, M., Mellinger, U., Krone, W., Jockenhövel, F.

Get full text